+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Ophthalmology Drugs Global Market Report 2019

  • ID: 4721159
  • Report
  • Region: Global
  • 300 pages
  • The Business Research Company
1 of 4

FEATURED COMPANIES

  • Allergan Plc
  • Bayer AG
  • F. Hoffmann-La Roche Ltd
  • Novartis AG
  • MORE
Ophthalmology Drugs Market Global Report 2019 provides the strategists, marketers and senior management with the critical information they need to assess the global ophthalmology drugs market.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Description:
Where is the largest and fastest growing market for the ophthalmology drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Ophthalmology Drugs market global report answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider pharmaceutical drugs market, and compares it with other markets.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.
  • The ophthalmology drugs market section of the report gives context. It compares the ophthalmology drugs market with other segments of the pharmaceutical drugs market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, ophthalmology drugs indicators comparison.
Scope

Markets Covered: Antiglaucoma Drugs, Dry Eye Medication, Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy)

Companies Mentioned: Novartis AG, F. Hoffmann-La Roche Ltd, Allergan Plc, Valeant Pharmaceuticals Intl Inc, Bayer AG

Metrics Covered: Number of Enterprises, Number of Employees

Countries: Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, Vietnam

Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Time series: Five years historic and forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita, ophthalmology drugs indicators comparison.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Allergan Plc
  • Bayer AG
  • F. Hoffmann-La Roche Ltd
  • Novartis AG
  • MORE
1. Executive Summary

2. Report Structure

3. Ophthalmology Drugs Market Characteristics
3.1. Market Definition
3.2. Key Segmentations

4. Ophthalmology Drugs Market Product Analysis
4.1. Leading Products/ Services
4.2. Key Features and Differentiators
4.3. Development Products

5. Ophthalmology Drugs Market Supply Chain
5.1. Supply Chain
5.2. Distribution
5.3. End Customers

6. Ophthalmology Drugs Market Customer Information
6.1. Customer Preferences
6.2. End Use Market Size and Growth

7. Ophthalmology Drugs Market Trends And Strategies

8. Ophthalmology Drugs Market Size And Growth
8.1. Market Size
8.2. Historic Market Growth, Value ($ Billion)
8.2.1. Drivers Of The Market
8.2.2. Restraints On The Market
8.3. Forecast Market Growth, Value ($ Billion)
8.3.1. Drivers Of The Market
8.3.2. Restraints On The Market

9. Ophthalmology Drugs Market Regional Analysis
9.1. Global Ophthalmology Drugs Market, 2018, By Region, Value ($ Billion)
9.2. Global Ophthalmology Drugs Market, 2014 - 2022, Historic And Forecast, By Region
9.3. Global Ophthalmology Drugs Market, Growth And Market Share Comparison, By Region

10. Ophthalmology Drugs Market Segmentation
10.1. Global Ophthalmology Drugs Market, Segmentation By Type, 2014 - 2022, Value ($ Billion)
10.1.1. Antiglaucoma Drugs
10.1.2. Dry Eye Medication
10.1.3. Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy)

11. Ophthalmology Drugs Market Metrics
11.1. Ophthalmology Drugs Market Size, Percentage Of GDP, 2014 - 2022, Global
11.2. Per Capita Average Ophthalmology Drugs Market Expenditure, 2014 - 2022, Global

12. Asia-Pacific Ophthalmology Drugs Market
12.1. Asia-Pacific Ophthalmology Drugs Market Overview
12.2. Asia-Pacific, Ophthalmology Drugs Market, 2018, By Country, Value ($ Billion)
12.3. Asia-Pacific, Ophthalmology Drugs Market, 2014 - 2022, Historic And Forecast, By Country
12.4. Asia-Pacific, Ophthalmology Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
12.5. Asia-Pacific, Ophthalmology Drugs Market Metrics
12.5.1. Per Capita Average Ophthalmology Drugs Expenditure, 2014 - 2022, Asia-Pacific Countries
12.6. Asia-Pacific Ophthalmology Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
12.7. Asia-Pacific Ophthalmology Drugs Market: Country Analysis
12.7.1. China Ophthalmology Drugs Market
12.7.1.1. China Ophthalmology Drugs Market Overview
12.7.1.2. China Ophthalmology Drugs Market, 2014 - 2022, Value ($ Billion)
12.7.1.3. China Ophthalmology Drugs Market, 2014 - 2022, Volume (Million Units)
12.7.1.4. China Ophthalmology Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
12.7.2. Australia Ophthalmology Drugs Market
12.7.2.1. Australia Ophthalmology Drugs Market, 2014 - 2022, Value ($ Billion)
12.7.2.2. Australia Ophthalmology Drugs Market, 2014 - 2022, Volume (Million Units)
12.7.2.3. Australia Ophthalmology Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
12.7.3. Hong Kong Ophthalmology Drugs Market
12.7.3.1. Hong Kong Ophthalmology Drugs Market, 2014 - 2022, Value ($ Billion)
12.7.4. India Ophthalmology Drugs Market
12.7.4.1. India Ophthalmology Drugs Market, 2014 - 2022, Value ($ Billion)
12.7.4.2. India Ophthalmology Drugs Market, 2014 - 2022, Volume (Million Units)
12.7.4.3. India Ophthalmology Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
12.7.5. Indonesia Ophthalmology Drugs Market
12.7.5.1. Indonesia Ophthalmology Drugs Market, 2014 - 2022, Value ($ Billion)
12.7.6. Japan Ophthalmology Drugs Market
12.7.6.1. Japan Ophthalmology Drugs Market, 2014 - 2022, Value ($ Billion)
12.7.6.2. Japan Ophthalmology Drugs Market, 2014 - 2022, Volume (Million Units)
12.7.6.3. Japan Ophthalmology Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
12.7.7. Malaysia Ophthalmology Drugs Market
12.7.7.1. Malaysia Ophthalmology Drugs Market, 2014 - 2022, Value ($ Billion)
12.7.8. New Zealand Ophthalmology Drugs Market
12.7.8.1. New Zealand Ophthalmology Drugs Market, 2014 - 2022, Value ($ Billion)
12.7.9. Philippines Ophthalmology Drugs Market
12.7.9.1. Philippines Ophthalmology Drugs Market, 2014 - 2022, Value ($ Billion)
12.7.10. Singapore Ophthalmology Drugs Market
12.7.10.1. Singapore Ophthalmology Drugs Market, 2014 - 2022, Value ($ Billion)
12.7.11. South Korea Ophthalmology Drugs Market
12.7.11.1. South Korea Ophthalmology Drugs Market, 2014 - 2022, Value ($ Billion)
12.7.12. Thailand Ophthalmology Drugs Market
12.7.12.1. Thailand Ophthalmology Drugs Market, 2014 - 2022, Value ($ Billion)
12.7.13. Vietnam Ophthalmology Drugs Market
12.7.13.1. Vietnam Ophthalmology Drugs Market, 2014 - 2022, Value ($ Billion)

13. Western Europe Ophthalmology Drugs Market
13.1. Western Europe Ophthalmology Drugs Market Overview
13.2. Western Europe, Ophthalmology Drugs Market, 2018, By Country, Value ($ Billion)
13.3. Western Europe, Ophthalmology Drugs Market, 2014 - 2022, Historic And Forecast, By Country
13.4. Western Europe, Ophthalmology Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
13.5. Western Europe, Ophthalmology Drugs Market Metrics
13.5.1. Per Capita Average Ophthalmology Drugs Expenditure, 2014 - 2022, Western Europe Countries
13.6. Western Europe Ophthalmology Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
13.7. Western Europe Ophthalmology Drugs Market: Country Analysis
13.7.1. Austria Ophthalmology Drugs Market
13.7.1.1. Austria Ophthalmology Drugs Market, 2014 - 2022, Value ($ Billion)
13.7.2. Belgium Ophthalmology Drugs Market
13.7.2.1. Belgium Ophthalmology Drugs Market, 2014 - 2022, Value ($ Billion)
13.7.3. Denmark Ophthalmology Drugs Market
13.7.3.1. Denmark Ophthalmology Drugs Market, 2014 - 2022, Value ($ Billion)
13.7.4. Finland Ophthalmology Drugs Market
13.7.4.1. Finland Ophthalmology Drugs Market, 2014 - 2022, Value ($ Billion)
13.7.5. France Ophthalmology Drugs Market
13.7.5.1. France Ophthalmology Drugs Market, 2014 - 2022, Value ($ Billion)
13.7.5.2. France Ophthalmology Drugs Market, 2014 - 2022, Volume (Million Units)
13.7.5.3. France Ophthalmology Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
13.7.6. Germany Ophthalmology Drugs Market
13.7.6.1. Germany Ophthalmology Drugs Market, 2014 - 2022, Value ($ Billion)
13.7.6.2. Germany Ophthalmology Drugs Market, 2014 - 2022, Volume (Million Units)
13.7.6.3. Germany Ophthalmology Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
13.7.7. Ireland Ophthalmology Drugs Market
13.7.7.1. Ireland Ophthalmology Drugs Market, 2014 - 2022, Value ($ Billion)
13.7.8. Italy Ophthalmology Drugs Market
13.7.8.1. Italy Ophthalmology Drugs Market, 2014 - 2022, Value ($ Billion)
13.7.8.2. Italy Ophthalmology Drugs Market, 2014 - 2022, Volume (Million Units)
13.7.8.3. Italy Ophthalmology Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
13.7.9. Netherlands Ophthalmology Drugs Market
13.7.9.1. Netherlands Ophthalmology Drugs Market, 2014 - 2022, Value ($ Billion)
13.7.10. Norway Ophthalmology Drugs Market
13.7.10.1. Norway Ophthalmology Drugs Market, 2014 - 2022, Value ($ Billion)
13.7.11. Portugal Ophthalmology Drugs Market
13.7.11.1. Portugal Ophthalmology Drugs Market, 2014 - 2022, Value ($ Billion)
13.7.12. Spain Ophthalmology Drugs Market
13.7.12.1. Spain Ophthalmology Drugs Market, 2014 - 2022, Value ($ Billion)
13.7.12.2. Spain Ophthalmology Drugs Market, 2014 - 2022, Volume (Million Units)
13.7.12.3. Spain Ophthalmology Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
13.7.13. Sweden Ophthalmology Drugs Market
13.7.13.1. Sweden Ophthalmology Drugs Market, 2014 - 2022, Value ($ Billion)
13.7.14. Switzerland Ophthalmology Drugs Market
13.7.14.1. Switzerland Ophthalmology Drugs Market2013 - 2022, Value ($ Billion)
13.7.15. UK Ophthalmology Drugs Market
13.7.15.1. UK Ophthalmology Drugs Market, 2014 - 2022, Value ($ Billion)
13.7.15.2. UK Ophthalmology Drugs Market, 2014 - 2022, Volume (Million Units)
13.7.15.3. UK Ophthalmology Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)

14. Eastern Europe Ophthalmology Drugs Market
14.1. Eastern Europe Ophthalmology Drugs Market Overview
14.2. Eastern Europe, Ophthalmology Drugs Market, 2018, By Country, Value ($ Billion)
14.3. Eastern Europe, Ophthalmology Drugs Market, 2014 - 2022, Historic And Forecast, By Country
14.4. Eastern Europe, Ophthalmology Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
14.5. Eastern Europe, Ophthalmology Drugs Market Metrics
14.5.1. Per Capita Average Ophthalmology Drugs Expenditure, 2014 - 2022, Eastern Europe Countries
14.6. Eastern Europe Ophthalmology Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
14.7. Eastern Europe Ophthalmology Drugs Market: Country Analysis
14.7.1. Czech Republic Ophthalmology Drugs Market,
14.7.1.1. Czech Republic Ophthalmology Drugs Market, 2014 - 2022, Value ($ Billion)
14.7.2. Poland Ophthalmology Drugs Market
14.7.2.1. Poland Ophthalmology Drugs Market, 2014 - 2022, Value ($ Billion)
14.7.3. Romania Ophthalmology Drugs Market
14.7.3.1. Romania Ophthalmology Drugs Market, 2014 - 2022, Value ($ Billion)
14.7.4. Russia Ophthalmology Drugs Market
14.7.4.1. Russia Ophthalmology Drugs Market, 2014 - 2022, Value ($ Billion)
14.7.4.2. Russia Ophthalmology Drugs Market, 2014 - 2022, Volume (Million Units)
14.7.4.3. Russia Ophthalmology Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)

15. North America Ophthalmology Drugs Market
15.1. North America Ophthalmology Drugs Market Overview
15.2. North America, Ophthalmology Drugs Market, 2018, By Country, Value ($ Billion)
15.3. North America, Ophthalmology Drugs Market, 2014 - 2022, Historic And Forecast, By Country
15.4. North America, Ophthalmology Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
15.5. North America, Ophthalmology Drugs Market Metrics
15.5.1. Per Capita Average Ophthalmology Drugs Expenditure, 2014 - 2022, North America Countries
15.6. North America Ophthalmology Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
15.7. North America Ophthalmology Drugs Market: Country Analysis
15.7.1. Canada Ophthalmology Drugs Market
15.7.1.1. Canada Ophthalmology Drugs Market, 2014 - 2022, Value ($ Billion)
15.7.2. Mexico Ophthalmology Drugs Market
15.7.2.1. Mexico Ophthalmology Drugs Market, 2014 - 2022, Value ($ Billion)
15.7.3. USA Ophthalmology Drugs Market
15.7.3.1. USA Ophthalmology Drugs Market Overview
15.7.3.2. USA Ophthalmology Drugs Market, 2014 - 2022, Value ($ Billion)
15.7.3.3. USA Ophthalmology Drugs Market, 2014 - 2022, Volume (Million Units)
15.7.3.4. USA Ophthalmology Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)

16. South America Ophthalmology Drugs Market
16.1. South America Ophthalmology Drugs Market Overview
16.2. South America, Ophthalmology Drugs Market, 2018, By Country, Value ($ Billion)
16.3. South America, Ophthalmology Drugs Market, 2014 - 2022, Historic And Forecast, By Country
16.4. South America, Ophthalmology Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
16.5. South America, Ophthalmology Drugs Market Metrics
16.5.1. Per Capita Average Ophthalmology Drugs Expenditure, 2014 - 2022, South America Countries
16.6. South America Ophthalmology Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
16.7. South America Ophthalmology Drugs Market: Country Analysis
16.7.1. Argentina Ophthalmology Drugs Market
16.7.1.1. Argentina Ophthalmology Drugs Market, 2014 - 2022, Value ($ Billion)
16.7.2. Brazil Ophthalmology Drugs Market
16.7.2.1. Brazil Ophthalmology Drugs Market, 2014 - 2022, Value ($ Billion)
16.7.2.2. Brazil Ophthalmology Drugs Market, 2014 - 2022, Volume (Million Units)
16.7.2.3. Brazil Ophthalmology Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
16.7.3. Chile Ophthalmology Drugs Market
16.7.3.1. Chile Ophthalmology Drugs Market, 2014 - 2022, Value ($ Billion)
16.7.4. Colombia Ophthalmology Drugs Market
16.7.4.1. Colombia Ophthalmology Drugs Market, 2014 - 2022, Value ($ Billion)
16.7.5. Peru Ophthalmology Drugs Market
16.7.5.1. Peru Ophthalmology Drugs Market, 2014 - 2022, Value ($ Billion)
16.7.6. Venezuela Ophthalmology Drugs Market
16.7.6.1. Venezuela Ophthalmology Drugs Market, 2014 - 2022, Value ($ Billion)

17. Middle East Ophthalmology Drugs Market
17.1. Middle East Ophthalmology Drugs Market Overview
17.2. Middle East, Ophthalmology Drugs Market, 2018, By Country, Value ($ Billion)
17.3. Middle East, Ophthalmology Drugs Market, 2014 - 2022, Historic And Forecast, By Country
17.4. Middle East, Ophthalmology Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
17.5. Middle East, Ophthalmology Drugs Market Metrics
17.5.1. Per Capita Average Ophthalmology Drugs Expenditure, 2014 - 2022, Middle East Countries
17.6. Middle East Ophthalmology Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
17.7. Middle East Ophthalmology Drugs Market: Country Analysis
17.7.1. Saudi Arabia Ophthalmology Drugs Market
17.7.1.1. Saudi Arabia Ophthalmology Drugs Market, 2014 - 2022, Value ($ Billion)
17.7.2. Israel Ophthalmology Drugs Market
17.7.2.1. Israel Ophthalmology Drugs Market, 2014 - 2022, Value ($ Billion)
17.7.3. Turkey Ophthalmology Drugs Market
17.7.3.1. Turkey Ophthalmology Drugs Market, 2014 - 2022, Value ($ Billion)
17.7.4. UAE Ophthalmology Drugs Market
17.7.4.1. UAE Ophthalmology Drugs Market, 2014 - 2022, Value ($ Billion)

18. Africa Ophthalmology Drugs Market
18.1. Africa Ophthalmology Drugs Market Overview
18.2. Africa, Ophthalmology Drugs Market, 2018, By Country, Value ($ Billion)
18.3. Africa, Ophthalmology Drugs Market, 2014 - 2022, Historic And Forecast, By Country
18.4. Africa, Ophthalmology Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
18.5. Africa, Ophthalmology Drugs Market Metrics
18.5.1. Per Capita Average Ophthalmology Drugs Expenditure, 2014 - 2022, Africa Countries
18.6. Africa Ophthalmology Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
18.7. Africa Ophthalmology Drugs Market: Country Analysis
18.7.1. Egypt Ophthalmology Drugs Market
18.7.1.1. Egypt Ophthalmology Drugs Market, 2014 - 2022, Value ($ Billion)
18.7.2. Nigeria Ophthalmology Drugs Market
18.7.2.1. Nigeria Ophthalmology Drugs Market, 2014 - 2022, Value ($ Billion)
18.7.3. South Africa Ophthalmology Drugs Market
18.7.3.1. South Africa Ophthalmology Drugs Market, 2014 - 2022, Value ($ Billion)

19. Ophthalmology Drugs Market Competitive Landscape
19.1. Competitive Market Overview
19.2. Market Shares
19.3. Company Profiles
19.3.1. Novartis AG
19.3.1.1. Company Overview
19.3.1.2. Company Ophthalmology Drugs Market Structure And Strategy
19.3.1.3. Company Ophthalmology Drugs Market Products And Services
19.3.1.4. Financial Performance
19.3.2. F. Hoffmann-La Roche Ltd
19.3.2.1. Company Overview
19.3.2.2. Company Ophthalmology Drugs Market Structure And Strategy
19.3.2.3. Company Ophthalmology Drugs Market Products And Services
19.3.2.4. Financial Performance
19.3.3. Allergan Plc
19.3.3.1. Company Overview
19.3.3.2. Company Ophthalmology Drugs Market Structure And Strategy
19.3.3.3. Company Ophthalmology Drugs Market Products And Services
19.3.3.4. Financial Performance
19.3.4. Valeant Pharmaceuticals Intl Inc
19.3.4.1. Company Overview
19.3.4.2. Company Ophthalmology Drugs Market Structure And Strategy
19.3.4.3. Company Ophthalmology Drugs Market Products And Services
19.3.4.4. Financial Performance
19.3.5. Bayer AG
19.3.5.1. Company Overview
19.3.5.2. Company Ophthalmology Drugs Market Structure And Strategy
19.3.5.3. Company Ophthalmology Drugs Market Products And Services
19.3.5.4. Financial Performance

20. Key Mergers And Acquisitions In The Ophthalmology Drugs Market

21. Market Background: Pharmaceutical Drugs Market
21.1. Pharmaceutical Drugs Market Characteristics
21.2. Pharmaceutical Drugs Market Historic and Forecast, 2014 - 2022 Growth, by segment, Value ($ Billion), Global
21.3. Global Pharmaceutical Drugs Market, 2018, By Region, Value ($ Billion)
21.4. Global Pharmaceutical Drugs Market, 2014 - 2022, Historic And Forecast, By Region
21.5. Global Pharmaceutical Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)

22. Recommendations
22.1. Global Ophthalmology Drugs Market In 2022- Growth Countries
22.2. Global Ophthalmology Drugs Market In 2022- Growth Segments
22.3. Global Ophthalmology Drugs Market In 2022- Growth Strategies

23. Appendix
23.1. NAICS Definitions Of Industry Covered In This Report
23.2. Abbreviations
23.3. Currencies
23.4. Research Inquiries
23.5. The publisher

24. Copyright And Disclaimer
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4

FEATURED COMPANIES

  • Allergan Plc
  • Bayer AG
  • F. Hoffmann-La Roche Ltd
  • Novartis AG
  • MORE
The ophthalmology drugs market consists of sales of ophthalmology drugs and related services by entities (organizations, sole traders and partnerships) that produce ophthalmology drugs to treat eye related diseases. This industry includes establishments that produce antiglaucoma drugs used to treat glaucoma diseases, anti- inflammatory and tear stimulating drugs under dry eye medications drugs, and other drugs for treating retinal disorders and allergies.

Asia Pacific was the largest region in the global ophthalmology drugs market, accounting for 36% of the market in 2018. North America was the second largest region accounting for 27% of the global ophthalmology drugs market. Africa was the smallest region in the global ophthalmology drugs market.

Drug manufacturers are developing new class of compounds called Rho-kinase inhibitors for the treatment of glaucoma. Rho-kinase pathway is an integral part of cellular functions such as contraction of vascular smooth muscle cells, organization of the actin cytoskeleton, cell adhesion and motility and gene expression. These inhibitors are different from widely used prostaglandin analogs because they target the outflow through trabecular meshwork rather than the uveoscleral outflow. Rho-kinase inhibitors have proved to decrease intraocular pressure by 25% to 30% with duration of action of 10 to 12 hours, which is more effective than the previous generation of drugs for this condition. Major Rho-kinase inhibitors being developed include ATS907, ATS8535, AR-12286, AR-13324, AMA0076 and BOL-303259-X.
Note: Product cover images may vary from those shown
5 of 4
  • Novartis AG
  • F. Hoffmann-La Roche Ltd
  • Allergan Plc
  • Valeant Pharmaceuticals Intl Inc
  • Bayer AG
Note: Product cover images may vary from those shown
Adroll
adroll